NEXENTIS TECHNOLOGIES INC. Payments for (Proceeds from) Businesses and Interest in Affiliates
NEXENTIS TECHNOLOGIES INC. (NXTS) reported Payments for (Proceeds from) Businesses and Interest in Affiliates of -$4.86 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-31.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsForProceedsFromBusinessesAndInterestInAffiliates · last filed 2022-03-31
- NEXENTIS TECHNOLOGIES INC. payments for (proceeds from) businesses and interest in affiliates for the quarter ending 2020-12-31 was -$1.00.
- NEXENTIS TECHNOLOGIES INC. payments for (proceeds from) businesses and interest in affiliates for the quarter ending 2020-09-30 was -$2.38K, a 115.75% decline year-over-year.
- NEXENTIS TECHNOLOGIES INC. payments for (proceeds from) businesses and interest in affiliates for the quarter ending 2019-12-31 was $0.00.
- NEXENTIS TECHNOLOGIES INC. payments for (proceeds from) businesses and interest in affiliates for the quarter ending 2019-09-30 was $15.13K.
- NEXENTIS TECHNOLOGIES INC. payments for (proceeds from) businesses and interest in affiliates for fiscal 2020 was -$4.86K, a 164.28% decline from fiscal 2019.
- NEXENTIS TECHNOLOGIES INC. payments for (proceeds from) businesses and interest in affiliates for fiscal 2019 was $7.57K.
| Period end | Payments for (Proceeds from) Businesses and Interest in Affiliates 3 month | Payments for (Proceeds from) Businesses and Interest in Affiliates 6 month | Payments for (Proceeds from) Businesses and Interest in Affiliates 6 month as first filed | Payments for (Proceeds from) Businesses and Interest in Affiliates 9 month | Payments for (Proceeds from) Businesses and Interest in Affiliates 12 month |
|---|---|---|---|---|---|
| 2020-12-31 | -$1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$2.38K derived: sum of 2 quarters · filed 2022-03-31 | -$4.86K 10-K · filed 2022-03-31 | ||
| 2020-09-30 | -$2.38K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$4.86K 10-Q · filed 2021-11-15 | |||
| 2020-06-30 | -$2.48K 10-Q · filed 2021-08-16 | $2.48K 10-Q · filed 2020-08-11 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $15.13K derived: sum of 2 quarters · filed 2021-03-29 | $7.57K 10-K · filed 2021-03-29 | ||
| 2019-09-30 | $15.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $7.57K 10-Q · filed 2020-11-12 | |||
| 2019-06-30 | -$7.57K 10-Q · filed 2020-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |